Multifunctional infrared-emitting composites
Disclosed is a method of non-invasive infrared imaging, comprising (a) administering a composition containing infrared-emitting particles which contain rare earth elements that emit in the short-wavelength infrared (SWIR) spectrum, where the particles are encapsulated with a biocompatible matrix to form downconverting encapsulated particles; and (b) irradiating with infrared radiation, where both excitation and emission spectra of the encapsulated particles are in the infrared region. Analogous methods of image-guided biomedical intervention, and drug tracking and delivery are also disclosed. Also disclosed is a composition for biomedical applications, containing infrared-emitting particles which contain rare earth-elements that emit in the short-wavelength infrared (SWIR) spectrum, where the particles are encapsulated with a biocompatible matrix to form downconverting encapsulated particles.
1. A composition for biomedical applications, comprising a plurality of infrared-emitting particles comprising rare earth-elements that emit in the short-wavelength infrared (SWIR) spectrum, wherein said infrared-emitting particles are directly encapsulated with a coacervated human serum albumin (HSA) shell to form spherical downconverting microcapsules comprising a plurality of said infrared-emitting particles, wherein said infrared-emitting particles have a size between 2 nm and 10 micrometers, wherein said microcapsules have a capsule size between 10 nm and 100 micrometers, and wherein said infrared-emitting particles have a relative size permitting the plurality of infrared-emitting particles to be loaded into said microcapsules.
2. The composition of claim 1 , wherein said HSA shell further comprises a pharmaceutical agent.
3. The composition of claim 1 , wherein said HSA shell further comprises one or more targeting molecules which direct said encapsulated infrared-emitting particles to a biological target.
4. The composition of claim 1 , wherein said infrared-emitting particles comprise CeF 3 doped with one or more rare earth elements selected from the group consisting of Yb, Nd, Tm, Er, Pr, Dy and Ho.
5. The composition of claim 1 , wherein said infrared-emitting particles further comprise one or more elements selected from the group consisting of La, Ce, Pm, Sm, Eu, Gd, Tb, and Lu.
6. The composition of claim 1 , wherein said infrared-emitting particles are a factor of about 10 or more smaller than said microcapsules.
7. The composition of claim 1 , wherein the infrared-emitting particles loading in said microcapsules ranges from 0.004 wt % to 94 wt %.
8. The composition of claim 7 , wherein the infrared-emitting particles loading in said microcapsules ranges from about 10 wt % to about 40 wt %.
9. A method of non-invasive infrared imaging of a biological object, comprising the steps of:
(a) administering to a biological object the composition of claim 1 ;
(b) irradiating said biological object with infrared radiation; and
(c) capturing infrared emission spectral images of said encapsulated infrared-emitting particles in said biological object;
wherein both excitation and emission spectra of the encapsulated infrared-emitting particles are in the infrared region.
10. The method of claim 9 , wherein said HSA shell further comprises a pharmaceutical agent.
11. The method of claim 9 , wherein said HSA shell further comprises one or more targeting molecules which direct said encapsulated infrared-emitting particles to a biological target.
12. The method of claim 9 , wherein said infrared-emitting particles comprise CeF 3 doped with one or more rare earth elements selected from the group consisting of Yb, Nd, Tm, Er, Pr, Dy and Ho.
13. The method of claim 9 , wherein said infrared-emitting particles further comprise one or more elements selected from the group consisting of La, Ce, Pm, Sm, Eu, Gd, Tb, and Lu.
14. The method of claim 9 , wherein said microcapsules have a capsule size between 10 nm and 300 nm.
15. The method of claim 9 , wherein said microcapsules have a capsule size between 100 nm and 300 nm.
16. The method of claim 9 , wherein said infrared-emitting particles are a factor of about 10 or more smaller than said microcapsules.
17. The method of claim 9 , wherein the infrared-emitting particle loading in said microcapsules ranges from 0.004 wt % to 94 wt %.
18. The method of claim 17 , wherein the infrared-emitting particle loading in said microcapsules ranges from about 10 wt % to about 40 wt %.
19. A method of drug tracking and delivery in a biological object, comprising the non-invasive infrared imaging method of claim 9 wherein said composition further comprises a drug.